BRPI0417076A - produção da toxina da difteria - Google Patents

produção da toxina da difteria

Info

Publication number
BRPI0417076A
BRPI0417076A BRPI0417076-8A BRPI0417076A BRPI0417076A BR PI0417076 A BRPI0417076 A BR PI0417076A BR PI0417076 A BRPI0417076 A BR PI0417076A BR PI0417076 A BRPI0417076 A BR PI0417076A
Authority
BR
Brazil
Prior art keywords
diphtheria toxin
production
analog
amino acid
methods
Prior art date
Application number
BRPI0417076-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Tim Lee
Xuefeng Yu
Original Assignee
Sanofi Pasteur Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur Ltd filed Critical Sanofi Pasteur Ltd
Publication of BRPI0417076A publication Critical patent/BRPI0417076A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0417076-8A 2003-12-12 2004-11-30 produção da toxina da difteria BRPI0417076A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48178003P 2003-12-12 2003-12-12
PCT/CA2004/002024 WO2005056773A1 (en) 2003-12-12 2004-11-30 Production of diphtheria toxin

Publications (1)

Publication Number Publication Date
BRPI0417076A true BRPI0417076A (pt) 2007-03-13

Family

ID=34676553

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417076-8A BRPI0417076A (pt) 2003-12-12 2004-11-30 produção da toxina da difteria

Country Status (12)

Country Link
US (1) US20110097359A1 (https=)
EP (1) EP1692269A4 (https=)
JP (1) JP2007513613A (https=)
KR (1) KR20060133994A (https=)
CN (1) CN1894399A (https=)
AU (1) AU2004297299A1 (https=)
BR (1) BRPI0417076A (https=)
CA (1) CA2546769A1 (https=)
IL (1) IL175873A0 (https=)
MX (1) MXPA06006630A (https=)
WO (1) WO2005056773A1 (https=)
ZA (1) ZA200604772B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006042542A2 (en) * 2004-10-19 2006-04-27 Statens Serum Institut Production of tetanus, diphtheria, and pertussis toxins and toxoids using fermentation media containing no components of animal or soy origin
US7375188B2 (en) * 2005-07-29 2008-05-20 Mallinckrodt Baker, Inc. Vegetarian protein a preparation and methods thereof
RS51999B (sr) * 2008-08-28 2012-04-30 Novartis Ag Dobijanje skvalena iz hiperprodukcijskih kvasaca
CN101503725B (zh) * 2009-03-19 2012-06-06 浙江天元生物药业有限公司 一种用于提高白喉类毒素纯度的工艺
AU2010201410B2 (en) * 2010-03-30 2015-04-30 Pelican Technology Holdings, Inc. High level expression of recombinant CRM197
EP2553102B1 (en) 2010-03-30 2015-12-09 Pfenex Inc. High level expression of recombinant toxin proteins
DE102011118371B4 (de) 2011-11-11 2014-02-13 Novartis Ag Zur Impfung von Menschen geeignete Zusammensetzung, die ein Diphtherie-Toxoid umfasst, sowie Verfahren zu deren Herstellung
DE102011122891B4 (de) 2011-11-11 2014-12-24 Novartis Ag Fermentationsmedium, das frei von tierischen Bestandteilen ist, zur Herstellung von Diphtherie-Toxoiden zur Verwendung bei der Impfung von Menschen
EP2592137A1 (en) 2011-11-11 2013-05-15 Novartis AG Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use
GB2495341B (en) * 2011-11-11 2013-09-18 Novartis Ag Fermentation methods and their products
AU2013203663B2 (en) * 2011-11-11 2015-05-28 Novartis Ag Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use
CN102766647A (zh) * 2012-07-25 2012-11-07 天津康希诺生物技术有限公司 在白喉杆菌中稳定复制的表达载体及含该载体的白喉杆菌
US10905146B2 (en) * 2013-07-12 2021-02-02 The Coca-Cola Company Compositions for improving rebaudioside M solubility
CN104027797B (zh) * 2014-06-19 2015-08-26 山东亦度生物技术有限公司 一种白喉疫苗的制备方法
CN104263678A (zh) * 2014-09-02 2015-01-07 成都欧林生物科技股份有限公司 一种白喉杆菌培养基及应用其制备白喉类毒素的方法
GB2556883A (en) * 2016-11-22 2018-06-13 Liebman Miriam Apparatus for transportation and storage of footwear
WO2018193475A2 (en) 2017-04-22 2018-10-25 Biological E Limited An improved method for high level production of crm
CN110452838B (zh) * 2019-07-18 2020-12-29 艾美卫信生物药业（浙江）有限公司 一种crm197菌种培养基、配制方法及发酵培养方法
CN114806973B (zh) * 2022-06-08 2024-02-23 艾美坚持生物制药有限公司 一种提高crm197蛋白产量的生长因子及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE372376T1 (de) * 1997-05-28 2007-09-15 Novartis Vaccines & Diagnostic Kulturmedium mit sojabohnenextrakt als aminosäuren-quelle und ohne proteinkomplexe tierischen ursprungs
US6558926B1 (en) * 1999-07-16 2003-05-06 Massachusetts Institute Of Technology Method for production of tetanus toxin using media substantially free of animal products

Also Published As

Publication number Publication date
IL175873A0 (en) 2006-10-05
KR20060133994A (ko) 2006-12-27
US20110097359A1 (en) 2011-04-28
JP2007513613A (ja) 2007-05-31
CN1894399A (zh) 2007-01-10
ZA200604772B (en) 2007-10-31
EP1692269A1 (en) 2006-08-23
EP1692269A4 (en) 2007-09-26
AU2004297299A1 (en) 2005-06-23
MXPA06006630A (es) 2007-04-16
WO2005056773A1 (en) 2005-06-23
CA2546769A1 (en) 2005-06-23

Similar Documents

Publication Publication Date Title
BRPI0417076A (pt) produção da toxina da difteria
NZ597769A (en) Proteins and nucleic acids from meningitis/sepsis-associated Escherichia Coli
DK0400958T3 (da) Levende vacciner
BRPI0509528A (pt) corpos imitação de glp-1 humana, composições, processos e usos
BR0312276A (pt) Mimeticorpos ch1-removidos miméticos de epo de mamìfero, composições, métodos e usos
BR0210804A (pt) Vacinação de dose única com mycoplásma hyopneumoniae
BRPI0113109B8 (pt) anticorpo de anti-il-12 isolado, composição e método para produzir o referido anticorpo
BR0315319A (pt) Terapias e procedimentos dentais com toxina botulìnica
BR0306432A (pt) Plantas e células vegetais transformadas e uso das mesmas, processo de cultura das plantas transformadas, processo para conferir uma tolerância aos inibidores de p-hidroxifenilpiruvirato dioxigenase às plantas, processo para aumentar a quantidade de prenilquinonas nas plantas e processo de produção de prenilquinonas
BRPI0410041A (pt) métodos para tratamento de dor de cabeça de sinusite
BRPI0511118A (pt) polipeptìdeos de haemophilus influenzae não transcritos
YU102103A (sh) Mycoplasma bovis vakcina i postupci redukovanja pneumonije kod životinja
BRPI0700640B8 (pt) sistema de restrição para formar uma restrição em um paciente
BRPI0418133A2 (pt) pró-fármaco de florfenicol tendo solubilidade em água melhorada
MXPA03011924A (es) Vacuna de micoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado.
CN104726439A (zh) 一种广谱的链球菌裂解酶及其应用
BR0303461A (pt) Bactéria que produz l-aminoácido pertencente ao gênero escherichia, e, método para a produção de l-aminoácido
DK1731500T3 (da) 5-aminolevulinsyre-phosphatsalt, fremgangsmåde til fremstilling deraf og anvendelse deraf
BRPI0609692C1 (pt) processos de fermentação e de fabricação de uma preparação de um antígeno de c. diphtheriae
SE8800991L (sv) Foerfarande foer framstaellning av alger med foerbaettrad biologisk verkan
DE69635472D1 (de) Impfstoff gegen Geflügelkokzidose
DK0653489T3 (da) Coccidiosisvaccine til fjerkræ
ATA145488A (de) Verwendung des enzym-cofaktors nadph zur herstellung eines arzneimittels
MD3625G2 (ro) Heptaazotat de hexa-(m-b-alanin-(O,O'))-m3-oxo-tri(aqua)trifier(III) 3,5-hidrat şi procedeu de obţinere a biomasei de Spirulina platensis
HN2003000015A (es) Sales estables del acido o acetilsalicilico con aminoacidos basicos i i.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.